Low-Dose Aspirin Safety, CVD Efficacy “Superior” To Higher Doses – McNeil
This article was originally published in The Tan Sheet
Executive Summary
Low-dose aspirin in the range of 81 mg-162 mg has a superior bleeding profile and similar efficacy to higher OTC doses for cardiovascular protection, Eric Topol, MD, Cleveland Clinic Foundation, told the FDA's Nonprescription Drugs Advisory Committee
You may also be interested in...
Aspirin 68% Mortality Reduction In Coronary Bypass Patients Seen In Study
Aspirin was associated with a 44%-70% reduction in major adverse events when taken within 48 hours of coronary-artery bypass surgery, according to a study in the Oct. 24 New England Journal of Medicine
Aspirin 68% Mortality Reduction In Coronary Bypass Patients Seen In Study
Aspirin was associated with a 44%-70% reduction in major adverse events when taken within 48 hours of coronary-artery bypass surgery, according to a study in the Oct. 24 New England Journal of Medicine
Aspirin 68% Mortality Reduction In Coronary Bypass Patients Seen In Study
Aspirin was associated with a 44%-70% reduction in major adverse events when taken within 48 hours of coronary-artery bypass surgery, according to a study in the Oct. 24 New England Journal of Medicine